PCTs ‘overspending’ on prescribing
May 24, 2007PCTs could save the NHS more than £200 million if they can persuade more GPs to prescribe generically, according to …
Report raises safety concerns over Avandia
May 24, 2007Sales and Marketing
GlaxoSmithKline has been forced on the defensive after its blockbuster diabetes treatment Avandia was linked to an increased risk of …
The Changing Face of Medical Education
May 23, 2007Medical Communications, Sales and Marketing medical education
Is Medical Education the new PR?Phil Sheldon, Managing Director, Resolute Communications:Clients are increasingly waking up to the fact that medical …
Charity outlines vision for tackling cancer
May 23, 2007Sales and Marketing
Cancer Research UK has set out an ambitious list of goals to reach by 2020, which it hopes will inspire …
Pfizer loses heads of research and finance
May 23, 2007Research and Development, Sales and Marketing
Two key Pfizer executives are to step down as the company continues its drive to reinvigorate itself.The departures follow the …
Edelman scoops European Viagra account
May 23, 2007Medical Communications
Pfizer has appointed PR agency Edelman to raise the European profile of its blockbuster erectile dysfunction treatment, Viagra.The company has …
Latest news from Datamonitor
May 23, 2007Sales and Marketing
Breast cancer patients may be offered chemo-free treatmentHormone therapy drugs such as AstraZeneca's Zoladex may be as effective as traditional …
Med Ed comes of age
May 17, 2007Medical Communications, Sales and Marketing medical education
Even a casual observer will have noticed the large contribution pharma makes to postgraduate medical education, both in the UK …
Roche selects Ketchum for pandemic work
May 17, 2007Medical Communications
PR agency Ketchum has scooped a global account for Tamiflu as Roche begins further research into its use against bird …
Clinical news from Datamonitor
May 17, 2007Research and Development
FDA requests additional efficacy data for Dendreon's Provenge in advanced prostate cancer.Dendreon has received a complete response letter from the …
Pharma news from Datamonitor
May 17, 2007Sales and Marketing
Meda and Ethypharm collaborate on NSAIDMeda and Ethypharm have signed an exclusive 15-year agreement for an innovative NSAID product which …
NICE blocks Erbitux for head and neck cancer
May 17, 2007Merck's targeted cancer drug Erbitux has been rejected by NICE for use against head and neck cancer.The Watchdog's Final Appraisal …
Gates Foundation could rival pharma, analysts warn
May 15, 2007Sales and Marketing Gates Foundation, HIV, TB, vaccines
The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …
GP prescribing costs contained in ’06
May 15, 2007Sales and Marketing
Pharma revenues from primary care prescribing in England edged up three per cent in 2006, with fewer GP-led product launches …
‘Research must be nurtured,’ says industry
May 15, 2007Research and Development
Nearly 1,000 potential future medicines are in the pipelines of some 50 companies operating in the UK, a survey by …
Date for NICE court showdown announced
May 14, 2007Sales and Marketing
NICE's decision to block access to Alzheimer's drugs will be put under legal scrutiny on 25 June when a much …
NHS managers praise Blair’s record
May 10, 2007News of Tony Blair's resignation as Prime Minister has been greeted with a tribute from NHS managers.Blair has announced he …
NICE attacks ‘flawed and inaccurate’ cancer report
May 10, 2007Andrew Dillon, the chief executive of NICE has hit out at a new report which says the UK has the …
Leapfrog leads Adventis’ online drive
May 10, 2007Medical Communications digi
Leapfrog has expanded its multimedia division as part of an investment drive into cutting-edge technologies by its parent company, marketing …
Novartis buys rights to smoking vaccine
May 10, 2007Research and Development, Sales and Marketing
Smokers who are addicted to the nicotine in their daily cigarettes could soon receive a vaccine to help them kick …
Latest content
FibroFind appoints Lee Borthwick as CEO
